Quinoline and Quinazoline Alkaloids against COVID‐19: An In Silico Multitarget Approach
EMOA Ismail, SW Shantier, MS Mohammed… - Journal of …, 2021 - Wiley Online Library
The recent outbreak of the highly contagious coronavirus disease 2019 (COVID‐19) caused
by the novel coronavirus SARS‐CoV‐2 has created a global health crisis with …
by the novel coronavirus SARS‐CoV‐2 has created a global health crisis with …
In silico insight into the interaction of 4-aminoquinolines with selected SARS-CoV-2 structural and nonstructural proteins
H Tijjani, A Olatunde, AP Adegunloye… - Coronavirus Drug …, 2022 - Elsevier
The development of efficacious therapeutic agents with relatively low or no level of toxicity
was necessitated due to the reemergence of coronavirus. The present study investigated the …
was necessitated due to the reemergence of coronavirus. The present study investigated the …
The antiviral and antimalarial drug repurposing in quest of chemotherapeutics to combat COVID-19 utilizing structure-based molecular docking
S Nandi, M Kumar, M Saxena… - … Chemistry & High …, 2021 - ingentaconnect.com
Background: The novel coronavirus disease (COVID-19) is caused by a new strain (SARS-
CoV-2) that erupted in 2019. Nowadays, it is a great threat that claims uncountable lives …
CoV-2) that erupted in 2019. Nowadays, it is a great threat that claims uncountable lives …
[PDF][PDF] Molecular Docking Assessment of Clinically Approved Antiviral Drugs against Mpro, Spike Glycoprotein and Angiotensin Converting Enzyme-2 Revealed …
TI Adelusi, M Abdul-Hammed, EM Ojo… - Tropical Journal of …, 2021 - researchgate.net
Ever since the novel SARS-CoV-2 coronavirus was identified at Wuhan in China, numerous
researchers have been working on remedies to ameliorate the COVID-19 disease …
researchers have been working on remedies to ameliorate the COVID-19 disease …
[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …
Discovery of Natural Bisbenzylisoquinoline Analogs from the Library of Thai Traditional Plants as SARS-CoV-2 3CLPro Inhibitors: In Silico Molecular Docking, Molecular …
N Khamto, K Utama, S Tateing… - Journal of Chemical …, 2023 - ACS Publications
The emergence of SARS-CoV-2 in December 2019 has become a global issue due to the
continuous upsurge in patients and the lack of drug efficacy for treatment. SARS-CoV-2 …
continuous upsurge in patients and the lack of drug efficacy for treatment. SARS-CoV-2 …
[HTML][HTML] Anthraquinone derivatives as an immune booster and their therapeutic option against COVID-19
Anthraquinone derivatives are identified for their immune-boosting, anti-inflammatory, and
anti-viral efficacy. Hence, the present study aimed to investigate the reported anthraquinone …
anti-viral efficacy. Hence, the present study aimed to investigate the reported anthraquinone …
[HTML][HTML] Indole alkaloids as potential candidates against COVID-19: an in silico study
COVID-19 has recently grown to be pandemic all around the world. Therefore, efforts to find
effective drugs for the treatment of COVID-19 are needed to improve humans' life quality and …
effective drugs for the treatment of COVID-19 are needed to improve humans' life quality and …
Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a dreaded pandemic in lack of specific …
syndrome coronavirus 2 (SARS-CoV-2), is a dreaded pandemic in lack of specific …
[HTML][HTML] Synthesis and in silico docking study towards M-pro of novel heterocyclic compounds derived from pyrazolopyrimidinone as putative SARS-CoV-2 inhibitors
M Horchani, NV Heise, R Csuk, H Ben Jannet… - Molecules, 2022 - mdpi.com
In addition to vaccines, antiviral drugs are essential in order to suppress COVID-19.
Although some inhibitor candidates have been determined to target the SARS-CoV-2 …
Although some inhibitor candidates have been determined to target the SARS-CoV-2 …